Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Abnormalities of the APC/β-catenin pathway in endometrial cancer

Abstract

The activation of the APC/β-catenin signalling pathway due to β-catenin mutations has been implicated in the development of a subset of endometrial carcinomas (ECs). However, up to 25% of ECs have β-catenin nuclear accumulation without evidence of β-catenin mutations, suggesting alterations of other molecules that can modulate the Wnt pathway, such as APC, γ-catenin, AXIN1 and AXIN2. We investigated the expression pattern of β- and γ-catenin in a group of 128 endometrial carcinomas, including 95 endometrioid endometrial carcinomas (EECs) and 33 non-endometrioid endometrial carcinomas (NEECs). In addition, we evaluated the presence of loss of heterozygosity and promoter hypermethylation of the APC gene and mutations in the APC, β- and γ-catenin, AXIN1, AXIN2, and RAS genes, and phospho-Akt expression. No APC mutations were detected but LOH at the APC locus was found in 24.3% of informative cases. APC promoter 1A hypermethylation was observed in 46.6% of ECs, and was associated with the endometrioid phenotype (P=0.034) and microsatellite instability (P=0.008). Neither LOH nor promoter hypermethylation of APC was associated with nuclear catenin expression. Nuclear β-catenin expression was found in 31.2% of EECs and 3% of NEECs (P=0.002), and was significantly associated with β-catenin gene exon 3 mutations (P<0.0001). β-catenin gene exon 3 mutations were associated with the endometrioid phenotype, and were detected in 14 (14.9%) EECs, but in none of the NEECs (P=0.02). γ-catenin nuclear expression was found in 10 ECs; it was not associated with the histological type but was associated with more advanced stages (P=0.042). No mutations in γ-catenin, AXIN1 and 2 genes were detected in this series. Neither RAS mutations nor phospho-Akt expression, which were found in 16 and 27.6% of the cases, respectively, were associated with β-catenin nuclear expression. Our results demonstrated a high prevalence of alterations in molecules of the APC/β-catenin pathway, but only mutations in β-catenin gene are associated with aberrant nuclear localization of β-catenin.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

Similar content being viewed by others

References

  • Aberle H, Bauer A, Stappert J, Kispert A, Kemler R . 1997 EMBO J. 16: 3797–3804

  • Bailey T, Biddlestone L, Shepherd N, Barr H, Warner PH, Jankowski J . 1998 Am. J. Pathol. 152: 135–144

  • Behrens J, Jerchow BA, Wurtele M, Grimm J, Asbrand C, Wirtz R, Kuhl M, Wedlich D, Birchmeier W . 1998 Science 280: 596–599

  • Boland CR, Thibodeau SN, Hamilton SR, Sidransky DA, Eshalman JR, Burt RW, Meltzer SJ, Rodríguez-Bigas MA, Fodde R, Ranzani GN, Srivastava SA . 1998 Cancer Res. 58: 5248–5257

  • Caca K, Kolling FT, Ji X, Hayes M, Qian J, Yahanda A, Rimm DL, Costa J, Fearon E . 1999 Cell Growth Diff. 10: 369–376

  • Chesire DR, Ewing CM, Gage WR, Isaacs WB . 2002 Oncogene 21: 2679–2694

  • Dahmen RP, Koch A, Denkhaus D, Tonn JC, Sörensen N, Berthold F, Behrens J, Birchmeier W, Wiestler OD, Pietsh T . 2001 Cancer Res. 61: 7039–7043

  • Desbois-Mouthon C, Cadoret A, Blivet-Van Eggelpoël MJ, Bertrand F, Cherqui G, Perret C, Capeau J . 2001 Oncogene 20: 252–259

  • Ding VW, Rui-Hong C, McCormick F . 2000 J. Biol. Chem. 275: 32475–32481

  • Dong SM, Kim H-S, Rha S-H, Sidransky D . 2001 Clin. Cancer Res. 7: 1982–1986

  • Duval A, Iacopetta B, Ranzani GN, Lothe RA, Thomas G, Hamelin R . 1999 Oncogene 18: 6806–6809

  • Espada J, Pérez-Moreno M, Braga VMM, Rodríguez-Viciana P, Cano A . 1999 J. Cell Biol. 146: 967–980

  • Esteller M, Levine R, Baylin SB, Hedrick Elleson L, Herman JG . 1998 Oncogene 17: 2413–2417

  • Esteller M, Spark A, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Gonzalez S, Tarafa G, Sidransky D, Meltzer J, Baylin SB, Herman JG . 2000 Cancer Res. 60: 4366–4371

  • Fearnhead NS, Britton MP, Bodmer WF . 2001 Hum. Mol. Genet. 10: 721–733

  • Fujino T, Risinger JI, Collins NK, Liu F, Nishii H, Takahasi H, Westphal E-M, Barrett JC, Sasaki H, Kohler F, Berchuck A, Boyd J . 1994 Cancer Res. 54: 4294–4298

  • Fukuchi T, Sakamoto M, Tsuda H, Maruyama K, Nozawa S, Hiroashi S . 1998 Cancer Res. 58: 3526–3528

  • Gamallo C, Palacios J, Moreno-Bueno G, Calvo de Mora J, Suárez A, Armas A . 1999 Am. J. Pathol. 155: 527–536

  • García-Rostán G, Camp RL, Herrero A, Carcangiu ML, Rimm DL, Tallini G . 2001 Am. J. Pathol. 158: 987–996

  • Gras E, Catasus L, Argüelles R, Moreno-Bueno G, Palacios J, Gamallo C, Matías-Guiu X, Prat J . 2001 Cancer 92: 2829–2836

  • He T-C, Spark AB, Rago C, Hemerking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW . 1998 Science 281: 1509–1512

  • Hsu W, Zeng L, Constantini F . 1999 J. Biol. Chem. 294: 3439–3445

  • Ikeda T, Yoshinaga K, Semba S, Kondo E, Ohmori H, Horii A . 2000 Oncol. Rep. 7: 323–326

  • Jin Z, Tamura G, Tsuchiya T, Sakata K, Kashiwaba M, Osakabe M, Motoyama T . 2001 Br. J. Cancer 85: 69–73

  • Jones MH, Koi S, Fujimoto I, Hasumi K, Kato K, Nakamura Y . 1994 Genes Chromosomes Cancer 9: 119–123

  • Kawakami K, Branbender J, Lord RV, Groshen S, Greenwald BD, Krasna MJ, Yin J, Fleisher S, Abraham JM, Beer D, Sidransky D, Huss HT, Demeester DR, Eads C, Laird PW, Ilson DH, Kelsen DP, Harpole D, Moore MB, Danenberg KD, Danenberg PV, Meltzer SJ . 2000 J. Natl. Cancer Inst. 92: 1805–1811

  • Kirchner T, Brabletz T . 2000 Am. J. Pathol. 157: 1113–1121

  • Kobayashi K, Sagae S, Nishioka Y, Tokino T, Kudo R . 1999 Jpn. J. Cancer Res. 90: 55–59

  • Kolligs FT, Kolligs B, Hajra KM, Hu G, Tani M, Cho KR, Fearon ER . 2000 Gen. Dev. 14: 1319–1331

  • Korinek V, Barker N, Morin PJ, Van Wichen D, de Weger R, Kinzler KW, Vogelstein B, Clevers H . 1997 Science 275: 1784–1787

  • Lin YM, Kato T, Satoh S, Nakamura Y, Furukawa Y . 2000 J. Hum. Genet. 45: 254–256

  • Liu W, Dong X, Mai M, Seelan RS, Taniguchi K, Krishnadath KK, Halling KC, Cunningham JM, Quian C, Christensen E, Roche PC, Smith DI, Thibodeau SN . 2000 Nat. Genet. 26: 146–147

  • Matias-Gviu X, Catasus L, Bussaglia E, Lagarda H, Garcia A, Pons C, Munoz J, Arguelles R, Machin P, Prat J . 2001 Human Pathol. 32: 569–577

  • Mirabelli-Primdahl L, Gryfe R, Kim H, Millar A, Luceri D, Dale D, Holowaty E, Bapap B, Gallinger S, Redston M . 1999 Cancer 59: 3346–3351

  • Moreno-Bueno G, Gamallo C, Perez-Gallego L, de Mora JC, Suarez A, Palacios J . 2001 Diag. Mol. Pathol. 10: 116–122

  • Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW . 1997 Science 275: 1787–1790

  • Nei H, Saito T, Yamasaki H, Mizumoto H, Ito E, Kudo R . 1999 Mol. Carcinog. 25: 207–218

  • Palacios J, Gamallo C . 1998 Cancer Res. 58: 1344–1347

  • Palacios J, Catasús L, Moreno-Bueno G, Matías-Guiu X, Prat J, Gamallo C . 2001 Virchows Arch. 438: 464–469

  • Perucho M . Correspondence re: CR Boland et al 1999 Cancer Res. 59: 249–256

  • Reinacher-Schick A, Gumbiner BM . 2001 J. Cell Biol. 152: 491–502

  • Rubinfeld BI, Albert I, Porfiri E, Fiol C, Munemitsu S, Polakis P . 1996 Science 272: 1023–1026

  • Saegusa M, Okayasu I . 2001 J. Pathol. 194: 59–67

  • Saegusa M, Hashimura M, Yoshida T, Okayasu I . 2001 Br. J. Cancer 84: 209–217

  • Samowitz WS, Holden JA, Curtin K, Edwards SL, Walker AR, Lin HA, Robertson MA, Nichols MF, Gruenthal KM, Lynch BJ, Leppert MF, Slattery M . 2001 Am. J. Pathol. 158: 1517–1524

  • Satoh S, Daigo Y, Furukawa Y, Kato T, Miwa N, Nishikawi T, Kawasoe T, Ishiguro H, Fujita M, Tokino T, Sasaki Y, Imaoka S, Murata M, Shimano T, Yamoka Y, Nakamura Y . 2000 Nat. Genet. 24: 245–250

  • Satyamoorthy K, Li G, Vaidya B, Patel D, Herlyn M . 2001 Cancer Res. 61: 7318–7324

  • Schosshauer PW, Pirog EC, Levine RL, Elleson LH . 2000 Mod. Pathol. 13: 1066–1071

  • Sharpe C, Lawrence N, Martinez Arias A . 2001 BioEssays 23: 311–318

  • Spark AB, Morin PJ, Vogelstein B, Kinzler KW . 1998 Cancer Res. 58: 1130–1134

  • Staal FJ, Burgering BM, van de Wetering M, Clevers HC . 1999 Int. Immunol. 11: 317–323

  • Tetsu O, McCormick F . 1999 Nature 398: 422–426

  • Tsuchiya T, Tamura G, Sato K, Sakata K, Jin Z, Motoyama T, Usuba O, Kimura W, Nishizuka S, Wilson KT, James SP, Yin J, Fleisher AS, Zou T, Silverberg SG, Kong D, Meltzer SJ . 2000 Oncogene 19: 3642–3646

  • Ueda M, Gemmill RM, West J, Winn R, Sugita M, Tanaka N, Ueki M, Drabkin HA . 2001 Br. J. Cancer 85: 64–68

  • Valizadeh A, Karayiannakis AJ, El-Hariry I, Kmiot W, Pignatelly M . 1997 Am. J. Pathol. 150: 1977–1984

  • Virmani AK, Rathi A, Sathyanarayama UG, Padar A, Huang CX, Cunningham HT, Farinas AJ, Milchgrub S, Euhus DM, Gilcrease M, Herman J, Minna JD, Gazdar AF . 2001 Clin. Cancer Res. 7: 1998–2004

  • Voeller HJ, Truica CI, Gelman EP . 1998 Cancer Res. 58: 2520–2523

  • Webster M-T, Rozycka M, Sara E, Davis E, Smalley M, Young N, Dale TC, Wooster R . 2000 Genes Chromosomes Cancer 28: 443–453

  • Willert K, Nusse R . 1998 Curr. Opin. Gen Development 8: 95–102

  • Wu R, Zhai Y, Fearon ER, Cho KR . 2001 Cancer Res. 61: 8247–8255

  • Yuan H, Mao J, Li L, Wu D . 1999 J. Biol. Chem. 274: 30419–30423

  • Zhou XP, Hoang JM, Li YJ, Seruca R, Carneiro F, Sobrinho-Simoes M, Lothe RA, Gleeson CM, Russel SEH, Muzeau F, Fléjou JF, Hoang-Zuang K, Lidereau R, Thomas G, Hamelin R . 1998 Genes Chromosomes Cancer 21: 101–107

  • Zysman M, Saka A, Millar A, Knight J, Chapman W, Bapat B . 2002 Cancer Res. 62: 3663–3666

Download references

Acknowledgements

Supported in part by grants FIS 01/0037-01 and SAF2001-0065. G Moreno-Bueno is a recipient of a postdoctoral research grant from the Centro Nacional de Investigaciones Oncológicas, Spain, and D Sarrió is a recipient of a BEFI grant from the Fondo de Investigaciones Sanitatias (01/9132), Spain.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to José Palacios.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Moreno-Bueno, G., Hardisson, D., Sánchez, C. et al. Abnormalities of the APC/β-catenin pathway in endometrial cancer. Oncogene 21, 7981–7990 (2002). https://doi.org/10.1038/sj.onc.1205924

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205924

Keywords

This article is cited by

Search

Quick links